Share-based Payment Arrangement, Expense of COLLEGIUM PHARMACEUTICAL, INC from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
COLLEGIUM PHARMACEUTICAL, INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • COLLEGIUM PHARMACEUTICAL, INC Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $7,596,000, a 8.5% increase year-over-year.
  • COLLEGIUM PHARMACEUTICAL, INC Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $32,400,000, a 19% increase year-over-year.
  • COLLEGIUM PHARMACEUTICAL, INC annual Share-based Payment Arrangement, Expense for 2024 was $32,400,000, a 19% increase from 2023.
  • COLLEGIUM PHARMACEUTICAL, INC annual Share-based Payment Arrangement, Expense for 2023 was $27,136,000, a 19% increase from 2022.
  • COLLEGIUM PHARMACEUTICAL, INC annual Share-based Payment Arrangement, Expense for 2022 was $22,874,000, a 5.7% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

COLLEGIUM PHARMACEUTICAL, INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $32,400,000 $7,596,000 +$594,000 +8.5% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
Q3 2024 $31,806,000 $7,317,000 +$290,000 +4.1% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $31,516,000 $10,012,000 +$2,940,000 +42% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $28,576,000 $7,475,000 +$1,440,000 +24% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $27,136,000 $7,002,000 +$1,332,000 +23% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $25,804,000 $7,027,000 +$1,650,000 +31% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $24,154,000 $7,072,000 +$1,380,000 +24% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $22,774,000 $6,035,000 -$100,000 -1.6% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $22,874,000 $5,670,000 +$758,000 +15% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $22,116,000 $5,377,000 -$571,000 -9.6% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $22,687,000 $5,692,000 -$824,000 -13% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $23,511,000 $6,135,000 -$744,000 -11% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $24,255,000 $4,912,000 -$1,298,000 -21% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $25,553,000 $5,948,000 +$783,000 +15% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $24,770,000 $6,516,000 +$932,000 +17% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $23,838,000 $6,879,000 +$1,928,000 +39% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $21,910,000 $6,210,000 +$2,244,000 +57% 01 Oct 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q3 2020 $19,666,000 $5,165,000 +$1,028,000 +25% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $18,638,000 $5,584,000 +$1,422,000 +34% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $17,216,000 $4,951,000 +$688,000 +16% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $16,528,000 $3,966,000 +$368,000 +10% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $16,160,000 $4,137,000 +$211,000 +5.4% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $15,949,000 $4,162,000 +$636,000 +18% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $15,313,000 $4,263,000 +$1,535,000 +56% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $13,778,000 $3,598,000 +$1,520,000 +73% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $12,258,000 $3,926,000 +$1,826,000 +87% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q2 2018 $10,432,000 $3,526,000 +$1,580,000 +81% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $8,852,000 $2,728,000 +$907,000 +50% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $7,945,000 $2,078,000 +$428,000 +26% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q3 2017 $7,517,000 $2,100,000 +$459,000 +28% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $7,058,000 $1,946,000 +$551,000 +39% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $6,507,000 $1,821,000 +$720,000 +65% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 $5,787,000 $1,650,000 01 Oct 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $1,641,000 +$1,138,000 +226% 01 Jul 2016 30 Sep 2016 10-Q 08 Nov 2017 2017 Q3
Q2 2016 $1,395,000 +$794,000 +132% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $1,101,000 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q3 2015 $503,000 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $601,000 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2

COLLEGIUM PHARMACEUTICAL, INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $32,400,000 +$5,264,000 +19% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2025 2024 FY
2023 $27,136,000 +$4,262,000 +19% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 $22,874,000 -$1,381,000 -5.7% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $24,255,000 +$2,345,000 +11% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $21,910,000 +$5,382,000 +33% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $16,528,000 +$2,750,000 +20% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $13,778,000 +$5,833,000 +73% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $7,945,000 +$2,158,000 +37% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $5,787,000 +$3,578,000 +162% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $2,209,000 +$2,187,000 +9941% 01 Jan 2015 31 Dec 2015 10-K 07 Mar 2018 2017 FY
2014 $22,000 -$40,000 -65% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $62,000 01 Jan 2013 31 Dec 2013 10-K 18 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.